Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunoprecipitation [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 18149-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#18149-1-AP, RRID:AB_2276580
- Product name
- CPLX2 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated CPLX2 antibody (Cat. #18149-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Absence of BBSome function leads to astrocyte reactivity in the brain.
Widespread cerebellar transcriptome changes in Ts65Dn Down syndrome mouse model after lifelong running.
Complexin-2 (CPLX2) as a potential prognostic biomarker in human lung high grade neuroendocrine tumors.
NOX2 deficiency ameliorates cerebral injury through reduction of complexin II-mediated glutamate excitotoxicity in experimental stroke.
Singh M, Garrison JE, Wang K, Sheffield VC
Molecular brain 2019 May 9;12(1):48
Molecular brain 2019 May 9;12(1):48
Widespread cerebellar transcriptome changes in Ts65Dn Down syndrome mouse model after lifelong running.
Walus M, Kida E, Rabe A, Albertini G, Golabek AA
Behavioural brain research 2016 Jan 1;296:35-46
Behavioural brain research 2016 Jan 1;296:35-46
Complexin-2 (CPLX2) as a potential prognostic biomarker in human lung high grade neuroendocrine tumors.
Komatsu H, Kakehashi A, Nishiyama N, Izumi N, Mizuguchi S, Yamano S, Inoue H, Hanada S, Chung K, Wei M, Suehiro S, Wanibuchi H
Cancer biomarkers : section A of Disease markers 2013;13(3):171-80
Cancer biomarkers : section A of Disease markers 2013;13(3):171-80
NOX2 deficiency ameliorates cerebral injury through reduction of complexin II-mediated glutamate excitotoxicity in experimental stroke.
Wang Z, Wei X, Liu K, Zhang X, Yang F, Zhang H, He Y, Zhu T, Li F, Shi W, Zhang Y, Xu H, Liu J, Yi F
Free radical biology & medicine 2013 Dec;65:942-951
Free radical biology & medicine 2013 Dec;65:942-951
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- human brain tissue were subjected to SDS PAGE followed by western blot with 18149-1-AP(CPLX2 antibody) at dilution of 1:1000
- Sample type
- tissue
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- IP Result of anti-CPLX2 (IP:18149-1-AP, 3ug; Detection:18149-1-AP 1:700) with SH-SY5Y cells lysate 800ug.
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human brain using 18149-1-AP(CPLX2 antibody) at dilution of 1:100 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CPLX2 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human CPLX2. This antibody recognizes human,mouse,rat antigen. The CPLX2 antibody has been validated for the following applications: ELISA, WB, IHC, IP analysis.